We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

101 hedge funds and large institutions have $20.5M invested in Definium Therapeutics in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more call options, than puts

Call options by funds: $20.9M | Put options by funds: $6.14M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

37% more capital invested

Capital invested by funds: $14.9M → $20.5M (+$5.59M)

19.01% more ownership

Funds ownership: 0.36% → 19.37% (+19%)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

35% less funds holding

Funds holding: 155 → 101 (-54)

75% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 72

Holders
101
Holders Change
-54
Holders Change %
-34.84%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
18
Increased
34
Reduced
34
Closed
72
Calls
$20.9M
Puts
$6.14M
Net Calls
+$14.7M
Net Calls Change
+$13.7M

Top Buyers

1
DCI
Data Collective IV
California
+$13.5M
2
MFG
Merit Financial Group
Georgia
+$10M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$9.6M
4
CH
CVI Holdings
Delaware
+$6.26M
5
EAM
Empery Asset Management
New York
+$1.8M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$1.76M
2
E
Ergoteles
New York
-$696K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$405K
4
LPL Financial
LPL Financial
California
-$324K
5
PCM
Penserra Capital Management
California
-$282K
Name Holding Trade Value Shares
Change 		Change in
Stake
NHC
126
Nicholas Hoffman & Company
Georgia
– -$7K -707 Closed
BZWA
127
Blue Zone Wealth Advisors
California
– -$6K -675 Closed
FNT
128
First National Trust
Pennsylvania
– -$6K -667 Closed
IAS
129
Investment Advisory Services
Texas
– -$6K -667 Closed
New York State Common Retirement Fund
130
New York State Common Retirement Fund
New York
– -$2K -204 Closed
US Bancorp
131
US Bancorp
Minnesota
– -$1K -133 Closed
PFGIA
132
Patriot Financial Group Insurance Agency
Massachusetts
– -$1K -129 Closed
SWM
133
Spire Wealth Management
Virginia
– -$1K -123 Closed
AW
134
ACG Wealth
Georgia
– -$1K -90 Closed
AWM
135
Avior Wealth Management
Nebraska
– -$672 -70 -74%
ARMC
136
American Research & Management Company
Massachusetts
– -$1K -67 Closed
HWM
137
HighMark Wealth Management
Minnesota
– -$298 -31 -21%
AF
138
Arrow Financial
New York
– -$10 -1 -1%
CWA
139
Clearview Wealth Advisors
Oregon
– -$10 -1 -1%
FWM
140
Focused Wealth Management
New York
– -$10 -1 -9%
JP Morgan Chase
141
JP Morgan Chase
New York
– -$10 -1 -6%
MA
142
Montag & Associates
Georgia
– -$10 -1 -25%
PFA
143
Professional Financial Advisors
Nebraska
– -$10 -1 -17%
Rockefeller Capital Management
144
Rockefeller Capital Management
New York
– -$10 -1 -0.7%
SBL
145
Sargent Bickham Lagudis
Colorado
– -$10 -1 -9%
TFGT
146
TS Financial Group (TSFG)
Illinois
– -$10 -1 -4%
WIM
147
Westside Investment Management
California
– -$10 -1 -1%
S
148
SignatureFD
Georgia
– +$19 +2 +100%
SIC
149
SJS Investment Consulting
Ohio
– +$19 +2 New
WFA
150
Wipfli Financial Advisors
Wisconsin
– +$58 +6 New
3 4 5
6
7

DFTX Hedge Fund Activity: Q3 2022 in Review

101 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2022, worth a combined $20.5M — up 37% from $14.9M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of DFTX and 18 opened new positions — a net loss of 54 holders — while 34 trimmed existing stakes and 34 added.

The largest buyer was Data Collective IV, adding an estimated $13.5M. The largest seller was Millennium Management, cutting an estimated $1.76M.

  • 101 institutional investors held Definium Therapeutics (DFTX) as of Q3 2022, down from 155 in Q2 2022.
  • Funds reported $20.5M of Definium Therapeutics stock for Q3 2022, up 37% quarter-over-quarter.
  • 18 funds opened new Definium Therapeutics positions in Q3 2022 and 72 closed out, a net change of -54 holders.
  • The largest Definium Therapeutics buyer in Q3 2022 was Data Collective IV, an estimated $13.5M added.
  • The largest Definium Therapeutics seller in Q3 2022 was Millennium Management, an estimated $1.76M sold.

Based on aggregated 13F filings for Q3 2022.